High rate of indigenous bronchiolitis and palivuzumab

J Paediatr Child Health. 2001 Aug;37(4):416-7. doi: 10.1046/j.1440-1754.2001.0720f.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents / economics
  • Antiviral Agents / therapeutic use*
  • Australia
  • Bronchiolitis, Viral / drug therapy*
  • Bronchiolitis, Viral / economics
  • Bronchiolitis, Viral / epidemiology
  • Humans
  • Incidence
  • Infant
  • Palivizumab
  • Respiratory Syncytial Virus Infections / drug therapy*
  • Respiratory Syncytial Virus Infections / epidemiology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Palivizumab